<strong>ARVO</strong> 2013 Annual Meeting Abstracts by Scientific Section/Group - <strong>Cornea</strong>displays a strong pH dependency, with enhanced tissue cross-linkingeffects occurring as the pH is raised from 6.5 to 9.5. As compared tocontrol tissue, the Ts using HNPD was shifted 1.5oC at pH 8.3, 3oCat pH 8.4, 3.8oC at pH 8.5, and 5.4oC at pH 9.5, indicating a pHdependent cross-linking effect. Similar shifts were observed usingboth MNPD and BP. Because Ts shifts of 2-2.5oC are observed usingthe standard riboflavin photochemical cross-linking technique, thisdegree of Ts shift represents our target effect. The type of buffer useddid not have a bearing on the pH dependent catalytic effect. Whenreacting at pH 7.4, 37oC, for 1hr, there were no discernible catalyticeffects using the three enzymes or DNA.Conclusions: Because the cornea can tolerate a pH up to 8.5 withoutsustaining damage, and the tear film has a fairly limited bufferingcapacity, modulating the pH of a BNA corneal cross-linking solutioncould provide a useful way to rapidly strengthen corneal tissue (i.e.within minutes).Commercial Relationships: David C. Paik, 12/517,382 andPCT/US2007/025126 (P); Quan Wen, None; Mi Jung Kim, None;Quan V. Hoang, None; Stephen L. Trokel, Avedro (C)Support: NIH Grant EY020495Program Number: 5285 Poster Board Number: C0204Presentation Time: 2:45 PM - 4:30 PMANALYSIS OF THICKNESS OF CORNEAS FROM EYEBANKS AFTER APPLICATION OF ISOSMOLARRIBOFLAVIN AND HIPOSMOLAR RIBOFLAVINLuiz Felipe L. Moraes 2, 1 , Luciene Barbosa 2 , Monique Macedo 2 ,Tatiana Rayes 2 . 1 Ophthalmology, Federal University of Pernambuco,Recife, Brazil; 2 Ophthalmology, Sorocaba Eye Bank, Sorocaba,Brazil.Purpose: Compare thickness of corneas from eye banks with200mOsm and 400mOsm riboflavin.Methods: <strong>Cornea</strong>s placed in artificial chamber had pachymetry withepithelium, without epithelium and 30 minutes after application ofanything (group 1-control); isosmolar (0,1% 400mOsm) riboflavin(group 2); hiposmolar (0,1% 200mOsm) riboflavin (group 3) andsaline solution (group 4).Results: 72 corneas were used; average prior pachymetry was 592μmand 548,8μm after removal of the epithelium. Group 1, 2 and 3 haddecrease in thickness and group 4 had an increase. The averagedecrease in group 2 was 68,95μm, more than twice the average ofgroup 3 (31,45μm).Conclusions: Hiposmolar riboflavin prevents the decrease inthickness when compared to isoosmolar riboflavin.Commercial Relationships: Luiz Felipe L. Moraes, None; LucieneBarbosa, None; Monique Macedo, None; Tatiana Rayes, NoneProgram Number: 5286 Poster Board Number: C0205Presentation Time: 2:45 PM - 4:30 PMCrosslinking <strong>Cornea</strong>l Collagen using Rose Bengal and GreenLightIrene E. Kochevar 1 , Thomas Gisel 1 , Erol E. Verter 1 , GiulianoScarcelli 1 , Seok H. Yun 1 , Robert H. Webb 1 , Robert W. Redmond 1 ,Samir Melki 2 . 1 Wellman Center for Photomedicine, MassachusettsGeneral Hospital, Boston, MA; 2 Boston Eye Group, Boston, MA.Purpose: We have previously shown that Rose Bengal (RB) plusgreen light markedly stiffens the corneal stroma by a rapid collagencrosslinking process that is not toxic to keratocytes. The goals of thisstudy were to determine the spatial localization of crosslinks, identifymechanisms and evaluate treatment safety.Methods: RB (0.1% in PBS) was applied to de-epithelialized rabbitcornea ex vivo for 2 min. The diffusion distance of RB into thestroma was evaluated on frozen sections by fluorescence microscopy.After irradiation of RB-stained cornea with green (532 nm) light froma KTP laser (10 min, 150 J/cm 2 ), the spatial distribution of increasedelastic modulus was determined by Brillouin scattering microscopyand the average stromal stiffness was measured by uniaxialtensiometry. The availability of oxygen in the stroma for thecrosslinking mechanism was evaluated by absorption spectroscopyduring the irradiation. The irradiance and fluence on the retina of amodel eye was measured using a newly designed light deliverysystem and compared to the ANSI standard damage thresholds.Results: RB penetration into the stroma was limited to ~120 µmfrom the anterior surface and did not increase over time. Consistentwith this distribution, Brillouin microscopy demonstrated increasedelastic modulus localized to the most anterior 120 µm of the stroma.Photo-crosslinking increased the average stromal stiffness by fourfoldcompared to untreated control cornea. Irradiation of RB-stainedcornea in the absence of oxygen shifted the absorption maximumfrom 562 nm to 520 nm, a signature of photoproducts formed onlyunder anoxic conditions. During photo-crosslinking the absorptionmaximum did not change suggesting an oxygen-dependentcrosslinking mechanism. The irradiance and fluence at the retina of amodel eye during the treatment were at least 20-fold below the ANSIdamage threshold for thermal or photochemical damage.Conclusions: The shallow penetration of RB into corneal stroma andformation of crosslinks within 120 µm of the anterior surface suggestthat thin corneas of keratoconus or other ectatic cornea conditions canbe treated. Photo-crosslinking rapidly and substantially increasescornea stiffness using safe retinal exposure levels of green light.Commercial Relationships: Irene E. Kochevar, Aura MedSystems(P); Thomas Gisel, None; Erol E. Verter, None; GiulianoScarcelli, massachusetts general hospital (P); Seok H. Yun,Massachusetts General Hospital (P); Robert H. Webb, None;Robert W. Redmond, Aura Medsystems Inc (C); Samir Melki,NoneProgram Number: 5287 Poster Board Number: C0206Presentation Time: 2:45 PM - 4:30 PMCollagen Crosslinking By Infrared Femtosecond Pulses In Exvivo<strong>Cornea</strong>sJuan M. Bueno, Harilaos S. Ginis, Raquel Palacios, AlexandrosPennos, Pablo Artal. Laboratorio de Optica, Universidad de Murcia,Murcia, Spain.Purpose: Collagen cross-linking (CXL) with ultraviolet (UV) A lightand riboflavin technique has been reported to increase cornealstiffness to slow down keratoconus progression. With UV CXLtreatment, irradiation is not localized and the penetration depthdepends on the attenuation of the UV light propagating through thecornea due to absorption within the riboflavin. This fact may lead toendothelial cell loss, especially in thin corneas. The purpose of thiswork was to determine if femtosecond (fs) infrared pulses couldinduce localized CXL effects through a 2-photon process on ex-vivoporcine corneas.Methods: A custom-made multiphoton microscope was used toirradiate a corneal volume and subsequently record multiphotonimages of the stroma. After de-epithelization, the eye was immersedinto a solution containing 0.125% riboflavin and 20% dextran during45 minutes. A set of control eyes were only immersed into 20%dextran solution in order to maintain their normal hydration. An area90×90×50 μm 3 within the cornea (depth location 125 μm, scanningstep 2 μm) was irradiated with the 760-nm fs-laser for 60 minutes inboth control and fs-CXL treated eyes.Results: During irradiation, multiphoton tomographic (XZ or YZ)images of the corneal stroma were adquired every 10 minutes forboth control and fs-CXL-treated corneas. For the former the©2013, Copyright by the Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Go to iovs.org to access the version of record. For permissionto reproduce any abstract, contact the <strong>ARVO</strong> Office at arvo@arvo.org.
<strong>ARVO</strong> 2013 Annual Meeting Abstracts by Scientific Section/Group - <strong>Cornea</strong>nonlinear signal presented a maximum close to the Bowman’s layerand a uniform decrease with depth typical of a non-irradiated cornea.On the opposite, fs-CXL corneas exhibited a marked increase innonlinear signal at the treated volume with no effect on nearbycorneal layers, presumably indicative of localized changes incollagen distribution. This was revealed by means of the regular XYmultiphoton images at different depth positions throughout the entirestroma.Conclusions: This study demonstrates the feasibility of usinginfrared fs-laser pulses to perform well-localized 3-dimensional CXLtreatments within the cornea. The technique has been proven to beprecise with surrounded regions hardly affected and no thermaleffects. The combination of both surgical and monitoring functionsinto a unique fs-laser system has the potential to be a tool in clinicalenvironments and could be the basis to establish a new techniquecapable of monitoring CXL procedures in real-time.Commercial Relationships: Juan M. Bueno, None; Harilaos S.Ginis, Universidad de Murcia (P); Raquel Palacios, None;Alexandros Pennos, None; Pablo Artal, AMO (C), Voptica SL (P),Voptica SL (I), AMO (F), Calhoun Vision (F), Calhoun Vision (C),AcuFocus (C)Support: Ministerio de Educación y Ciencia, Spain (grants FIS2010-14926 and CSD2007-00013) and Fundación Séneca, Región deMurcia, Spain (grant 4524/GERM/06).Program Number: 5288 Poster Board Number: C0207Presentation Time: 2:45 PM - 4:30 PMAccelerated corneal cross-linking with pulsed lightPavel Kamaev, William A. Eddington, Sara Rood-Ojalvo, Marc D.Friedman, David Muller. Research, Avedro, Waltham, MA.Purpose: <strong>Cornea</strong>l collagen cross-linking (CXL) with riboflavin (RF)strengthens corneas affected by keratoconus. This treatment involvesirradiation with continuous ultraviolet-A (UVA) which deoxygenatesthe cornea and makes keratocytes more susceptible to theaction of light. In order to avoid this self-limiting factor of CXL, wepropose to apply pulsed UVA to allow the tissue to re-oxygenate andto increase efficiency of CXL.Methods: Porcine eye globes were shipped overnight on ice from anabattoir (SiouxPreme, Sioux City, IA). The corneas were then deepithelializedand 0.1% riboflavin-5’-phosphate solution was appliedtopically during 20 min at 37°C. Eyes were placed in a beaker filledwith oxygen and irradiated for 3 min continuously or for 6 minuteswith pulsed UVA light (365 nm, 1.5 sec on / 1.5 sec off) at 30mW/cm2 using a shutter (Sutter Instrument, Novato, CA). <strong>Cornea</strong>lflaps (200 µm thick) were excised from the eyes using an Intralasefemtosecond laser (Abbot Medical Optics, Santa Ana, CA). The flapswere placed into a biaxial extensometer (CellScale Biotester 5000,Waterloo, ON), using biorake attachments with 5 tines spanning awidth of 3mm. Each sample was stretched at a constant rate of 4µm/s in saline at 37°C until sample failure. The flaps were thenwashed with distilled water, dried in a vacuum and digested at 65°Cwith 2.5 units/ml of papain in 1x PBS (pH 7.4) containing 2 mM L-cysteine and 2 mM EDTA. Fluorescence of the papain digests wasrecorded at 450 nm in a QM-40 Spectrofluorometer (PhotonTechnology Int., London, Ontario, Canada) using excitation of 360nm.Results: Continuous irradiation of the corneal tissue in presence ofRF resulted in a quick depletion of dissolved oxygen. This happensvia the process of generation of reactive oxygen species (includingsinglet oxygen) and following cross-linking, mediated by freeradicals. With pulsed fractionation of UVA radiation, cross-linkingefficiency is improved by allowing the re-diffusion of oxygen duringpauses in exposure.Conclusions: Our work confirmed that re-oxygenation of corneaduring UVA pulsation increases efficiency of the CXL. From aclinical perspective, accelerated CXL with pulsed light would lead toa reduced dose for the same amount of corneal stiffening andtherefore a better safety profile.Commercial Relationships: Pavel Kamaev, Avedro (E); WilliamA. Eddington, Avedro Inc. (E); Sara Rood-Ojalvo, Avedro Inc. (E);Marc D. Friedman, Avedro Inc (E); David Muller, Avedro Inc (E)Program Number: 5289 Poster Board Number: C0208Presentation Time: 2:45 PM - 4:30 PMLong term follow-up of stiffening of rabbit corneas by WST11using near infrared lightArie L. Marcovich 1, 2 , Alexander Brandis 1 , Ilan Feine 3 , Iddo Pinkas 1 ,Ruth Goldschmidt 1 , Vyacheslav Kalchenko 4 , Daniel H. Wagner 5 ,Yoram Salomon 3 , Avigdor Scherz 1 . 1 Plant Sciences, WeizmannInstitute of Science, Rehovot, Israel; 2 Ophthalmology, KaplanMedical Center, Rehovot, Israel; 3 Biological Regulation, WeizmannInstitute of Science, Rehovot, Israel; 4 Veterinary Resources,Weizmann Institute of Science, Rehovot, Israel; 5 Materials andInterfaces, Weizmann Institue of Science, Los Angeles, CA.Purpose: To evaluate the efficacy and safety of photochemicalcorneal stiffening by Pd- bacteriochlorin 13’-(2-sulfoethyl)-amidedipotassium salt (WST11) and near infrared (NIR) illumination,using rabbit eye models.Methods: <strong>Cornea</strong>s of living rabbits were pretreated topically with 2.5mg/ml WST11 in saline or in 20% dextran T-500 for 20 minutes, andilluminated with a NIR diode laser (755 nm, 10 mW/cm2) for 30minutes. <strong>Cornea</strong>s of untreated fellow eyes served as controls. Therabbits were sacrificed after one month and 4 months. <strong>Cornea</strong>l stripsof 4 mm width were excised. Ultimate stress and Young’s modulusmeasurements were performed using a biomechanical tester.Comparative studies were performed with standardriboflavin/ultraviolet-A light (UVA) treatment. Histology, electronspin resonance, fluorescence microscopy and optical coherencetomography (OCT) were used to evaluate treatment effects.Results: WST11/NIR treatment significantly increased cornealstiffness following treatment, compared to untreated contralateraleyes. After 1 month the ultimate stress and Young’s modulus oftreated corneas increased by 113%, and 80% respectively. WST11 in20% dextran T-500/NIR had similar stiffening results, but markedlyreduced post-treatment edema and time of epithelial healingcompared to WST11 without dextran. After 4 months, treated corneasmaintained biomechanical stiffness values measured at 1 month posttreatment. OCT demonstrated a demarcation line in the anterior thirdof the corneal stroma. Histology showed a reduction in the keratocytepopulation in the anterior half of the corneal stroma, without damageto the endothelium. Electron spin resonance demonstrated thatWST11/NIR generates hydroxyl and superoxide radicals but nosinglet oxygen in the cornea. These results, in particular whencombined with additional optical spectroscopy techniques, suggest anovel mechanism for corneal stiffening that has not been so faranticipated in connection with current stiffening approaches.Conclusions: Treatment of rabbit corneas, with thebacteriochlorophyll derivative WST11 and NIR illumination,increased their biomechanical strength through mechanism that doesnot involve singlet oxygen. WST11 in 20% dextran T-500/NIRtreatment showed less adverse effects. This treatment may have apotential for clinical use in keratoconus and corneal ectasia.Commercial Relationships: Arie L. Marcovich, Yeda Researchand Development Company, Weizmann Institute of Science (P);Alexander Brandis, Yeda Research and Development CompanyLtd., Weizmann Institute of Science (P); Ilan Feine, None; Iddo©2013, Copyright by the Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Go to iovs.org to access the version of record. For permissionto reproduce any abstract, contact the <strong>ARVO</strong> Office at arvo@arvo.org.
- Page 2 and 3:
ARVO 2013 Annual Meeting Abstracts
- Page 4 and 5:
ARVO 2013 Annual Meeting Abstracts
- Page 6 and 7:
ARVO 2013 Annual Meeting Abstracts
- Page 8 and 9:
ARVO 2013 Annual Meeting Abstracts
- Page 10:
ARVO 2013 Annual Meeting Abstracts
- Page 13 and 14:
ARVO 2013 Annual Meeting Abstracts
- Page 16 and 17:
ARVO 2013 Annual Meeting Abstracts
- Page 18 and 19:
ARVO 2013 Annual Meeting Abstracts
- Page 20 and 21:
ARVO 2013 Annual Meeting Abstracts
- Page 22 and 23:
ARVO 2013 Annual Meeting Abstracts
- Page 24 and 25:
ARVO 2013 Annual Meeting Abstracts
- Page 26 and 27:
ARVO 2013 Annual Meeting Abstracts
- Page 28 and 29:
ARVO 2013 Annual Meeting Abstracts
- Page 30 and 31:
ARVO 2013 Annual Meeting Abstracts
- Page 32 and 33:
ARVO 2013 Annual Meeting Abstracts
- Page 34 and 35:
ARVO 2013 Annual Meeting Abstracts
- Page 36 and 37:
ARVO 2013 Annual Meeting Abstracts
- Page 38 and 39:
ARVO 2013 Annual Meeting Abstracts
- Page 40 and 41:
ARVO 2013 Annual Meeting Abstracts
- Page 42 and 43:
ARVO 2013 Annual Meeting Abstracts
- Page 44 and 45:
ARVO 2013 Annual Meeting Abstracts
- Page 46 and 47:
ARVO 2013 Annual Meeting Abstracts
- Page 48 and 49:
ARVO 2013 Annual Meeting Abstracts
- Page 50 and 51:
ARVO 2013 Annual Meeting Abstracts
- Page 52 and 53:
ARVO 2013 Annual Meeting Abstracts
- Page 54 and 55:
ARVO 2013 Annual Meeting Abstracts
- Page 56 and 57:
ARVO 2013 Annual Meeting Abstracts
- Page 58 and 59:
ARVO 2013 Annual Meeting Abstracts
- Page 60 and 61:
ARVO 2013 Annual Meeting Abstracts
- Page 62 and 63:
ARVO 2013 Annual Meeting Abstracts
- Page 64 and 65:
ARVO 2013 Annual Meeting Abstracts
- Page 66 and 67:
ARVO 2013 Annual Meeting Abstracts
- Page 68 and 69:
ARVO 2013 Annual Meeting Abstracts
- Page 70 and 71:
ARVO 2013 Annual Meeting Abstracts
- Page 72 and 73:
ARVO 2013 Annual Meeting Abstracts
- Page 74 and 75:
ARVO 2013 Annual Meeting Abstracts
- Page 76 and 77:
ARVO 2013 Annual Meeting Abstracts
- Page 78 and 79:
ARVO 2013 Annual Meeting Abstracts
- Page 80 and 81:
ARVO 2013 Annual Meeting Abstracts
- Page 82 and 83:
ARVO 2013 Annual Meeting Abstracts
- Page 84 and 85:
ARVO 2013 Annual Meeting Abstracts
- Page 86 and 87:
ARVO 2013 Annual Meeting Abstracts
- Page 88 and 89:
ARVO 2013 Annual Meeting Abstracts
- Page 90 and 91:
ARVO 2013 Annual Meeting Abstracts
- Page 92 and 93:
ARVO 2013 Annual Meeting Abstracts
- Page 94 and 95:
ARVO 2013 Annual Meeting Abstracts
- Page 96 and 97:
ARVO 2013 Annual Meeting Abstracts
- Page 98 and 99:
ARVO 2013 Annual Meeting Abstracts
- Page 100 and 101:
ARVO 2013 Annual Meeting Abstracts
- Page 102 and 103:
ARVO 2013 Annual Meeting Abstracts
- Page 104 and 105:
ARVO 2013 Annual Meeting Abstracts
- Page 106 and 107:
ARVO 2013 Annual Meeting Abstracts
- Page 108 and 109:
ARVO 2013 Annual Meeting Abstracts
- Page 110 and 111:
ARVO 2013 Annual Meeting Abstracts
- Page 112 and 113:
ARVO 2013 Annual Meeting Abstracts
- Page 114 and 115:
ARVO 2013 Annual Meeting Abstracts
- Page 116 and 117:
ARVO 2013 Annual Meeting Abstracts
- Page 118 and 119:
ARVO 2013 Annual Meeting Abstracts
- Page 120 and 121:
ARVO 2013 Annual Meeting Abstracts
- Page 122 and 123:
ARVO 2013 Annual Meeting Abstracts
- Page 124 and 125:
ARVO 2013 Annual Meeting Abstracts
- Page 126 and 127:
ARVO 2013 Annual Meeting Abstracts
- Page 128 and 129:
ARVO 2013 Annual Meeting Abstracts
- Page 130 and 131:
ARVO 2013 Annual Meeting Abstracts
- Page 132 and 133:
ARVO 2013 Annual Meeting Abstracts
- Page 134 and 135:
ARVO 2013 Annual Meeting Abstracts
- Page 136 and 137:
ARVO 2013 Annual Meeting Abstracts
- Page 138 and 139:
ARVO 2013 Annual Meeting Abstracts
- Page 140 and 141:
ARVO 2013 Annual Meeting Abstracts
- Page 142 and 143:
ARVO 2013 Annual Meeting Abstracts
- Page 144 and 145:
ARVO 2013 Annual Meeting Abstracts
- Page 146 and 147:
ARVO 2013 Annual Meeting Abstracts
- Page 148 and 149:
ARVO 2013 Annual Meeting Abstracts
- Page 150 and 151:
ARVO 2013 Annual Meeting Abstracts
- Page 152 and 153:
ARVO 2013 Annual Meeting Abstracts
- Page 154 and 155:
ARVO 2013 Annual Meeting Abstracts
- Page 156 and 157:
ARVO 2013 Annual Meeting Abstracts
- Page 158 and 159:
ARVO 2013 Annual Meeting Abstracts
- Page 160 and 161:
ARVO 2013 Annual Meeting Abstracts
- Page 162 and 163:
ARVO 2013 Annual Meeting Abstracts
- Page 164 and 165:
ARVO 2013 Annual Meeting Abstracts
- Page 166 and 167:
ARVO 2013 Annual Meeting Abstracts
- Page 168 and 169:
ARVO 2013 Annual Meeting Abstracts
- Page 170 and 171:
ARVO 2013 Annual Meeting Abstracts
- Page 172 and 173:
ARVO 2013 Annual Meeting Abstracts
- Page 174 and 175:
ARVO 2013 Annual Meeting Abstracts
- Page 176 and 177:
ARVO 2013 Annual Meeting Abstracts
- Page 178 and 179:
ARVO 2013 Annual Meeting Abstracts
- Page 180 and 181:
ARVO 2013 Annual Meeting Abstracts
- Page 182 and 183:
ARVO 2013 Annual Meeting Abstracts
- Page 184 and 185:
ARVO 2013 Annual Meeting Abstracts
- Page 186 and 187:
ARVO 2013 Annual Meeting Abstracts
- Page 188 and 189:
ARVO 2013 Annual Meeting Abstracts
- Page 190 and 191:
ARVO 2013 Annual Meeting Abstracts
- Page 192 and 193:
ARVO 2013 Annual Meeting Abstracts
- Page 194 and 195:
ARVO 2013 Annual Meeting Abstracts
- Page 196 and 197:
ARVO 2013 Annual Meeting Abstracts
- Page 198 and 199:
ARVO 2013 Annual Meeting Abstracts
- Page 200 and 201:
ARVO 2013 Annual Meeting Abstracts
- Page 202 and 203:
ARVO 2013 Annual Meeting Abstracts
- Page 204 and 205:
ARVO 2013 Annual Meeting Abstracts
- Page 206 and 207:
ARVO 2013 Annual Meeting Abstracts
- Page 208 and 209:
ARVO 2013 Annual Meeting Abstracts
- Page 210 and 211:
ARVO 2013 Annual Meeting Abstracts
- Page 212 and 213:
ARVO 2013 Annual Meeting Abstracts
- Page 214 and 215:
ARVO 2013 Annual Meeting Abstracts
- Page 216 and 217:
ARVO 2013 Annual Meeting Abstracts
- Page 218 and 219:
ARVO 2013 Annual Meeting Abstracts
- Page 220 and 221:
ARVO 2013 Annual Meeting Abstracts
- Page 222 and 223:
ARVO 2013 Annual Meeting Abstracts
- Page 224 and 225:
ARVO 2013 Annual Meeting Abstracts
- Page 226 and 227:
ARVO 2013 Annual Meeting Abstracts
- Page 228 and 229:
ARVO 2013 Annual Meeting Abstracts
- Page 230 and 231:
ARVO 2013 Annual Meeting Abstracts
- Page 232 and 233:
ARVO 2013 Annual Meeting Abstracts
- Page 234 and 235:
ARVO 2013 Annual Meeting Abstracts
- Page 236 and 237:
ARVO 2013 Annual Meeting Abstracts
- Page 238 and 239:
ARVO 2013 Annual Meeting Abstracts
- Page 240 and 241:
ARVO 2013 Annual Meeting Abstracts
- Page 242 and 243:
ARVO 2013 Annual Meeting Abstracts
- Page 244 and 245:
ARVO 2013 Annual Meeting Abstracts
- Page 246 and 247:
ARVO 2013 Annual Meeting Abstracts
- Page 248 and 249:
ARVO 2013 Annual Meeting Abstracts
- Page 250 and 251:
ARVO 2013 Annual Meeting Abstracts
- Page 252 and 253:
ARVO 2013 Annual Meeting Abstracts
- Page 254 and 255:
ARVO 2013 Annual Meeting Abstracts
- Page 256 and 257:
ARVO 2013 Annual Meeting Abstracts
- Page 258 and 259:
ARVO 2013 Annual Meeting Abstracts
- Page 260 and 261:
ARVO 2013 Annual Meeting Abstracts
- Page 262 and 263:
ARVO 2013 Annual Meeting Abstracts
- Page 264 and 265:
ARVO 2013 Annual Meeting Abstracts
- Page 266 and 267:
ARVO 2013 Annual Meeting Abstracts
- Page 268 and 269:
ARVO 2013 Annual Meeting Abstracts
- Page 270 and 271: ARVO 2013 Annual Meeting Abstracts
- Page 272 and 273: ARVO 2013 Annual Meeting Abstracts
- Page 274 and 275: ARVO 2013 Annual Meeting Abstracts
- Page 276 and 277: ARVO 2013 Annual Meeting Abstracts
- Page 278 and 279: ARVO 2013 Annual Meeting Abstracts
- Page 280 and 281: ARVO 2013 Annual Meeting Abstracts
- Page 282 and 283: ARVO 2013 Annual Meeting Abstracts
- Page 284 and 285: ARVO 2013 Annual Meeting Abstracts
- Page 286 and 287: ARVO 2013 Annual Meeting Abstracts
- Page 288 and 289: ARVO 2013 Annual Meeting Abstracts
- Page 290 and 291: ARVO 2013 Annual Meeting Abstracts
- Page 292 and 293: ARVO 2013 Annual Meeting Abstracts
- Page 294 and 295: ARVO 2013 Annual Meeting Abstracts
- Page 296 and 297: ARVO 2013 Annual Meeting Abstracts
- Page 298 and 299: ARVO 2013 Annual Meeting Abstracts
- Page 300 and 301: ARVO 2013 Annual Meeting Abstracts
- Page 302 and 303: ARVO 2013 Annual Meeting Abstracts
- Page 304 and 305: ARVO 2013 Annual Meeting Abstracts
- Page 306 and 307: ARVO 2013 Annual Meeting Abstracts
- Page 308 and 309: ARVO 2013 Annual Meeting Abstracts
- Page 310 and 311: ARVO 2013 Annual Meeting Abstracts
- Page 312 and 313: ARVO 2013 Annual Meeting Abstracts
- Page 314 and 315: ARVO 2013 Annual Meeting Abstracts
- Page 316 and 317: ARVO 2013 Annual Meeting Abstracts
- Page 318 and 319: ARVO 2013 Annual Meeting Abstracts
- Page 322 and 323: ARVO 2013 Annual Meeting Abstracts
- Page 324 and 325: ARVO 2013 Annual Meeting Abstracts
- Page 326 and 327: ARVO 2013 Annual Meeting Abstracts
- Page 328 and 329: ARVO 2013 Annual Meeting Abstracts
- Page 330 and 331: ARVO 2013 Annual Meeting Abstracts
- Page 332 and 333: ARVO 2013 Annual Meeting Abstracts
- Page 334 and 335: ARVO 2013 Annual Meeting Abstracts
- Page 336 and 337: ARVO 2013 Annual Meeting Abstracts
- Page 338 and 339: ARVO 2013 Annual Meeting Abstracts
- Page 340 and 341: ARVO 2013 Annual Meeting Abstracts
- Page 342 and 343: ARVO 2013 Annual Meeting Abstracts
- Page 344 and 345: ARVO 2013 Annual Meeting Abstracts
- Page 346 and 347: ARVO 2013 Annual Meeting Abstracts
- Page 348 and 349: ARVO 2013 Annual Meeting Abstracts
- Page 350 and 351: ARVO 2013 Annual Meeting Abstracts
- Page 352 and 353: ARVO 2013 Annual Meeting Abstracts
- Page 354 and 355: ARVO 2013 Annual Meeting Abstracts
- Page 356 and 357: ARVO 2013 Annual Meeting Abstracts
- Page 358 and 359: ARVO 2013 Annual Meeting Abstracts
- Page 360 and 361: ARVO 2013 Annual Meeting Abstracts
- Page 362 and 363: ARVO 2013 Annual Meeting Abstracts
- Page 364 and 365: ARVO 2013 Annual Meeting Abstracts
- Page 366 and 367: ARVO 2013 Annual Meeting Abstracts
- Page 368 and 369: ARVO 2013 Annual Meeting Abstracts
- Page 370 and 371:
ARVO 2013 Annual Meeting Abstracts
- Page 372 and 373:
ARVO 2013 Annual Meeting Abstracts
- Page 374 and 375:
ARVO 2013 Annual Meeting Abstracts
- Page 376 and 377:
ARVO 2013 Annual Meeting Abstracts
- Page 378 and 379:
ARVO 2013 Annual Meeting Abstracts
- Page 380 and 381:
ARVO 2013 Annual Meeting Abstracts
- Page 382 and 383:
ARVO 2013 Annual Meeting Abstracts